3 Recruiting Breast Adenocarcinoma Phase 3 Clinical Trials
Active phase 3 studies for breast adenocarcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Breast Adenocarcinoma studiesPhase 3 Studies for Breast Adenocarcinoma
🔵 Active, Not Recruiting Phase3
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
📍 Northeast Alabama Regional Medical Center — Anniston, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
📍 Northeast Alabama Regional Medical Center — Anniston, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
📍 Southern Cancer Center PC-Mobile — Mobile, Alabama
View Study & Checklist ➔